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ABSTRACT       
Open Access is the online access to scientific journal literature, free of charge 
and free of most copyright and licensing restrictions. Open Access was named 
one of the top science news stories of 2003 by Nature, Science, The Scientist, 
and The Wall Street Journal. Open Access is supported by major science 
funding bodies, such as Howard Hughes Medical Institute (USA), the 
Wellcome trust (UK), the Max Planck Society, the DFG (Germany), the 
CNRS and INSERM (France). Rapidly rising conventional journal prices have 
been denounced by leading research universities (Harvard, Stanford, Cornell, 
Duke, more), found dysfunctional/unsustainable by independent financial 
analysts (PNB Paribas, Citigroup, Credit Suisse), and are now under 
investigation by Science and Technology Committee of the United Kingdom 
House of Commons. The advantages of an Open Access journal are 
compelling: articles are accessible to everyone with an internet connection; 
authors reach larger audiences and have greater impact; no permission is 
needed for copying, printing, distributing, storing or other educational uses; 
copyright remains with authors. Open Access does not violate copyright, but Koudinov and Suber: Open access, a breakthrough for science 
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uses the consent of the copyright holder. Open Access journals are peer-
reviewed and use the same high standards (ex. WAME) as conventional 
journals. Open Access journals are indexed in major databases (ex. National 
Institutes of Health, National Library of Medicine PubMed; ISI Science 
Citation Index) and major search engines (Google, Yahoo). Open Access 
journals may deposit copies of their articles in central archives (ex. PubMed 
Central), enhancing their preservation/availability. There are different funding 
models for Open Access journals in different circumstances; their costs are 
usually paid by the same sources that fund research. Of a thousand Open 
Access Journals listed in the Directory of Open Access Journals (DOAJ) many 
have no publication charge. Some journalss are entirely Open Access (ex. 
PLoS Biology), and some conventional journals are experimenting with Open 
Access (ex. PNAS). Scientists who publish in conventional journals can 
provide Open Access to the same articles by depositing them in Open Access 
archives. Open Access accelerates research, shares knowledge, improves the 
usefulness and citation of science journals articles. Wider adoption of Open 
Access depends on educating the scientific community about its benefits. Koudinov and Suber: Open access, a breakthrough for science 
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NEUROSCIENCE 2004 PRESS BOOK ARTICLE  
(by Alexei Koudinov) 
Web-links rich version of this article is freely available at http://neurobiologyoflipids.org/openaccess/sfn2004.html 
 
“Free access to taxpayer funded research globally may soon  
be within grasp, and make possible the freer flow of medical  
knowledge that strengthens our capacity to find cures and to  
improve lives” (An Open Letter to the US Congress  
Signed by 25 Nobel Prize Winners, 26 Aug 2004) 
 
   In a recent Financial Times article Arie Jongejan, CEO, Sci & Tech, Elsevier (May 26, 
2004, p.16) stated that "the scientific community has achieved a stable, scale-able and 
affordable system of [Scientific, Technical & Medical (STM)] publishing that adapts 
and invests in its information needs".  Koudinov and Suber: Open access, a breakthrough for science 
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      Apparently, the article by Reed Elsevier top official in a leading UK financial 
newspaper targeted investors and legislators, and aimed to preserve the centuries-long 
conventional STM publishing business where Elsevier presently is a biggest player.  
      What Elsevier S&T CEO calls "a stable ... and affordable system of [STM] 
publishing" put University Senates across US in great distress, resulted in a wave of 
cancellations of many subscription-access journals by leading Universities (Harvard, 
Stanford, Cornell, Duke, more), found dysfunctional and unsustainable by independent 
financial analysts (PNB Paribas, Citigroup, Credit Suisse), and is now under 
investigation by The appropriations committee of the US House of Representatives, and 
Science and Technology Committee of the United Kingdom (UK) House of Commons.  
   An unaffordable pricing and subscription bundling of Elseviers' Cell Press journals 
(including the major neuroscience title Neuron, and the most expensive Brain Research) 
with other Elsevier journals are the reasons for leading scientists' call to boycott these Koudinov and Suber: Open access, a breakthrough for science 
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serials by all those who actually make a scientific publication a prestigious journal, i.e 
contributors, peer reviewers, and editorial board members. The latter fact made evident 
the academic world unity in opposing the spiraling cost of subscription based journals 
and giving away the ownership in the scientific publication(a scientists' ultimate output) 
in a form of a copyright transfer to a publisher.  
      I agree with Daniel Greenstein (Associate Vice Provost, Scholarly Info, Univ of 
California; Univ Librarian, Systemwide Library Planning & California Digital Library) 
that "the business model of commercial publishing, which once served the academy's 
information needs, now threatens fundamentally to undermine and pervert the course of 
research and teaching... If business as usual continues, it will deny scholars both access 
to the information they need and the ability to distribute their work to the worldwide 
audience it deserves."  Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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   "The formula works, so don't tinker with it" argues FT article headline. Sadly, there is 
a discrepancy between Elsevier S&T CEO quote of "the stability of an efficient market" 
and his publishing house recent statement. Thus, just several months ago, on Dec. 3, 
2003, Elsevier Today announced that "the existing S&T portals, BioMedNet, 
ChemWeb, ElsevierEngineering.com will be withdrawn... [and that] this difficult 
decision has been made in the context of an extremely challenging budget brought about 
by the continued tough market conditions."  
      The business will apparently never continue as usual for subscription-based STM 
publishers. This is because the Internet Age raised Open Access (OA), that is (not to be 
misled by Elsevier and others defining it as "author-pay" model) the online access to 
scientific scholar journal literature, free of charge and free of most copyright and 
licensing restrictions.  Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
 
8 
   An OA journal advantages are obvious. Copyright usually remains with authors, so 
OA publisher does not violate copyright law, but uses the consent of the copyright 
holder, allowing articles' unlimited usage for both scientific research and educational 
purpose. OA journal quality is warranted by the conformity in fulfilling high standard 
policies (ex. World Association of Medical Editors, WAME) and the peer review. OA 
journal indexing in major databases (ex. NIH PubMed, ISI Science Citation Index) is 
subjected to rigorous selection process equal for all journals. To enhance the 
sustainability, OA journals can deposit articles in central archives and depository 
libraries (ex. PubMed Central by the NIH).  
   Open Access critique is based on the publication fee by some OA publishers "such as 
BioMedCentral (BMC) in the UK and Public Library of Science (PLoS) in the US" as 
exampled in the FT article. It is more accurate, however, to identify OA as funded by 
sources other then subscription revenues. Only a portion of OA journals has a Koudinov and Suber: Open access, a breakthrough for science 
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publication fee, representing an 'authors-pay' business model of OA publishing. 
However, of a thousand OA journals listed in the Directory of OA Journals (DOAJ) 
many have no publication charge.  
      While Open Access movement became powerful, subscription based journals are 
engaging in experimentation with OA, with the recent most illustrative example by The 
Proceedings of the National Academy of Sciences USA (PNAS), the flagship journal of 
the National Academy of Sciences. "The benefits to science of unfettered access to the 
literature are obvious and unassailable," says PNAS Editor-in-Chief Nicolas Cozarelli, 
in the editorial announcing "[authors-pay] OA option for PNAS contributors (June 8, 
2004 p. 8509), whereby authors may pay a surcharge of $1,000 to make their article 
freely available online upon publication… Although I have no doubt that open access 
will be made to work for much of the scientific literature, I am not sure how," adds 
Professor Cozarelli.  Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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      In the most recent editorial (Aug 16, 2004) PNAS Editor further announced 
"liberalization of PNAS copyright policy: noncommercial use [of publications is now] 
freely allowed".  
   Ironically, one way of OA, a deposition of articles in Open Access archives, was 
recently accepted by Elsevier, according to the letter by Karen Hunter (Elsevier Senior 
Vice President, Strategy) cross posted at several OA discussion boards (May 23, 2004). 
According to this Elsevier announcement "an author [of "published articles, whether 
published electronically or in print"] may post his or her version of the final paper on 
personal web site and on the institution's web site (including its institutional 
respository)..." [The permission to post published work in an archive is now introduced 
by several traditional publishers] 
   Such a mechanism of Open Access whereby authors (in addition to publication in 
peer-reviewed journals) deposit their articles in OA institutional repositories, was one of Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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82 recommendations and specific conlcusions of the UK House of Commons Sci Tech 
Committee report "Scientific Publications: Free for All?" (July 20, 2004). The 
committee held a thorough inquiry for half a year, conducted four sessions of oral 
testimony, hearing from 23 witnesses, and received 143 written submissions. It heard 
from leaders in research, libraries, universities and publishing (including those from the 
US) who put forward their arguments for and against OA.  
   At the same time, on July 14, the US House Appropriations Committee adopted a set 
of recommendations for next year's federal budget. One key recommendation would 
have the National Institutes of Health (NIH) put a condition on its research grants so that 
articles based on NIH-funded research would be deposited in PubMed Central, the NIH's 
OA digital library.  
   Of major importance is the "strong support for the House Appropriations Committee’s 
direction to NIH to develop an open, taxpayer access policy" by a panel of twenty five Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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Nobel prize winners. Quoting Nobel Laureates Open Letter to the U.S. Congress (Aug 
26, 2004): "The trend towards open access is gaining momentum. Japan, France and the 
United Kingdom are beginning to establish their own digital repositories for sharing 
content with NIH's PubMed Central. Free access to taxpayer funded research globally 
may soon be within grasp, and make possible the freer flow of medical knowledge that 
strengthens our capacity to find cures and to improve lives… We specifically ask you to 
support the House Appropriations Committee language as well as NIH leadership in 
adopting this long overdue reform."  
   In addition to OA archives and OA journals by big publishing houses (such as non-
profit PLoS and for-profit BMC) there is a different Open Access experience. It is 
provided by the Neurobiology of Lipids (NoL), a non-profit independent scholar serial 
that I organized, publish and lead as managing editor with no help of a commercial 
publisher or any online journal publishing provider (ex. Highwire Press, ScholarOne).  Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
13 
   Neurobiol Lipids concept is that OA can benefit the Society as a non-profit model for 
cost-effective independent scholar journals with no publication charge. NoL takes the 
advantage of an irreversible Internet and desktop publishing technology development 
and their end user availability at almost no cost.  
   Similarly to other OA journals, NoL serves all its' content free of charge immediately 
upon publication. NoL, however, welcomes free voluntary registration by readers in 
order to build the community of scholars working on or interested in the subject of the 
journal scope. NoL mission is "to provide worldwide leadership in advancing the 
knowledge of the neurobiology of lipids and its application to health care." Fats and 
cholesterol neurobiology are causative to Alzheimer's disease and several other brain 
pathologies, as my group pioneering research (summarized in another 34th SFN Annual 
Meeting 2004 teaching session by Koudinova et al.) and studies by others showed 
several years ago. NoL has no analogs among other neuroscience or lipid reserch Koudinov and Suber: Open access, a breakthrough for science 
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publications. Perhaps, this is in part a reason an online readership of NoL is comparable 
with the readership of the worlds' major Journal of Lipid Research (JLR) published since 
1959 (four-months average of 52.716 hits per month for NoL vs. 140.000 hits per month 
for JLR).  
   Lately, Neurobiology of Lipids publishing experience was translated into the launch of 
the Doping Journal , another independent OA scholar journal, debuted during the Athens 
Olympic games 2004. Both journals are running at an annual cost below a publication 
fee of one article at BMC (500$).  
   While wider adoption of Open Access depends on educating the scientific community 
about its benefits, the wider dissemination of independent publishing in the 
Neurobiology of Lipids way depends on still missing academic education about the 
technology and its' end-user friendly capabilities. The commercial publishers (both 
traditional and Open Access) are not interested in educating the academic world about Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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the ease of the modern electronic publishing, a critical issue to safeguard the commercial 
publishing cabal.  
      Therefore, educational courses on independent publishing technology should be 
developed and included in higher education curriculum. Furthermore, grant funds, 
faculty opportunities and academic education for independent publishing should be a 
priority for governments, charitable institutions, libraries, and academic institutions.  
   To facilitate the deveopment of new independent Open Access scholar publications 
Neurobiology of Lipids will provide necessary advisory for quality editorial groups 
willing to establish and independently run OA non-profit scientific journals.  
   The complete version of this lay article will be shortly available as Neurobiology of 
Lipids publication, and is in immediate free access at 
http://neurobiologyoflipids.org/openaccess/sfn2004.html.  
 Koudinov and Suber: Open access, a breakthrough for science 
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OPEN ACCESS OVERVIEW BY PETER SUBER 
( Available at: http://www.earlham.edu/~peters/fos/overview.htm ) 
 
Open Access Overview by Peter Suber is an excellent "introduction to open access (OA) for 
those who are new to the concept... It's short enough to read, long enough to be useful, and 
organized to let you skip around and dive into detail only where you want detail. It doesn't 
cover every nuance or answer every objection; that would require much more space. But for 
those who read it, it should cover enough territory to prevent the misunderstandings that 
delayed progress in our early days...“ 
 
Once you're acquainted with the general idea of OA, follow new developments through Peter 
Suber OA News Blog and newsletter, and see what you can do to help the cause.  
 Koudinov and Suber: Open access, a breakthrough for science 
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NATIONAL INSTITUTES OF HEALTH NOTICE AND CALL 
FOR COMMENTS: ENHANCED PUBLIC ACCESS TO NIH 
RESEARCH INFORMATION  
(Notice Number: NOT-OD-04-064, Release Date: September 3, 2004) 
Web-links rich gateway citation of this article is at http://neurobiologyoflipids.org/openaccess/openaccess2004.html 
 
   “The National Institutes of Health (NIH) is dedicated to improving the health of Americans 
by conducting and funding biomedical research that will help prevent, detect, treat and 
reduce the burdens of disease and disability. In order to achieve these goals, it is essential to 
ensure that scientific information arising from NIH-funded research is available in a timely 
fashion to other scientists, health care providers, students, teachers, and the many millions of 
Americans searching the web to obtain credible health-related information. NIH’s mission 
includes a long-standing commitment to share and support public access to the results and 
accomplishments of the activities that it funds. Koudinov and Suber: Open access, a breakthrough for science 
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      Establishing a comprehensive, searchable electronic resource of NIH- funded research 
results and providing free access to all, is perhaps the most fundamental way to collect and 
disseminate this information. The NIH must balance this need with the ability of journals and 
publishers to preserve their critical role in the peer review, editing and scientific quality 
control process. The economic and business implications of any changes to the current 
paradigm must be considered as the NIH weighs options to ensure public access to the results 
of studies funded with public support without compromising the quality of the information 
being provided. The NIH has established and intends to maintain a dialogue with publishers, 
investigators, and representatives from scientific associations and the public to ensure the 
success of this initiative.  
   This notice is to announce and to seek public comments regarding NIH’s plans to facilitate 
enhanced public access to NIH health related research information. NIH intends to request 
that its grantees and supported Principal Investigators provide the NIH with electronic copies 
of all final version manuscripts upon acceptance for publication if the research was supported Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
19 
in whole or in part by NIH funding. This would include all research grants, cooperative 
agreements, contracts, as well as National Research Service Award (NRSA) fellowships. We 
define final manuscript as the author’s version resulting after all modifications due to the 
peer review process. Submission of the final manuscript will provide NIH supported 
investigators with an alternate means by which they will meet and fulfill the requirement of 
the provision of one copy of each publication in the annual or final progress reports. 
Submission of the electronic versions of final manuscripts will be monitored as part of the 
annual grant progress review and close-out process.  
   NIH considers final manuscripts to be an important record of the research funded by the 
government and will archive these manuscripts and any appropriate supplementary 
information in PubMed Central (PMC), NIH’s digital repository for biomedical research. Six 
months after an NIH supported research study’s publication—or sooner if the publisher 
agrees—the manuscript will be made available freely to the public through PMC. If the 
publisher requests, the author’s final version of the publication will be replaced in the PMC Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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archive by the final publisher’s copy with an appropriate link to the publisher’s electronic 
database.  
      As with NIH’s DNA sequence and genetics databases, this digital archive in PMC is 
expected to be fully searchable to enhance retrieval and can be shared with other 
international digital repositories to maximize archiving and to provide widespread access to 
this information. It is anticipated that investigators applying for new and competing renewal 
support from the NIH will utilize this resource by providing links in their applications to their 
PubMed archived information. This practice will increase the efficiency of the application 
and review process.  
   NIH trusts that the up to six month delay to public archiving in PMC recommended by the 
policy will not result in unreasonable or disproportionate charges to grantees. As with all 
other costs, NIH expects its grantees to be careful stewards of Federal funds and to carefully 
manage these resources. We will carefully monitor requested budgets and other costing Koudinov and Suber: Open access, a breakthrough for science 
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information and would consider options to ensure that grantees’ budgets are not unduly 
affected by this policy.  
Comments 
The NIH encourages comments concerning its intentions to enhance public access to NIH-
funded health related research information as outlined in this notice. Comments on short term 
impacts and suggestions for mitigating these are especially welcome. We encourage that all 
comments be directed to the following NIH website: http://grants.nih.gov/grants/guide/ 
public_access/add.htm. As an alternative, comments may be submitted by email to the 
following address: PublicAccess@nih.gov. Comments must be received within 60 days of 
publication of this notice. NIH intends to publish an identical notice in the Federal Register.” 
 
NAS ENDORSES NIH PLAN FOR OPEN ACCESS  
Source: http://www.pnas.org/cgi/content/abstract/0407071101v1 
 Koudinov and Suber: Open access, a breakthrough for science 
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“The governing Council of the National Academy of Sciences (NAS), which includes five 
NAS officers and 12 members elected at large, has endorsed the National Institutes of Health 
proposed (NIH) policy by which papers reporting research funded by NIH would be freely 
available online at PubMed (PMC) not later than 6 months Central after publication.” …“We 
reaffirm our conviction that the interests of both in biomedicine and other areas are best 
science served by ensuring that ideas and information are as freely and rapidly as possible. 
We look exchanged to participating in the continuing evolution of forward publishing, and 
we applaud the NIH for taking scientific this important step.”  (PNAS October 19, 2004, Vol.101, 
p.14991) 
 
LEADERSHIP OF THE US LIBRARY ASSOCIATIONS 
SUPPORTS NIH PLAN ON OPEN ACCESS  
Web-links rich gateway citation of this article is at http://neurobiologyoflipids.org/openaccess/openaccess2004.html 
 Koudinov and Suber: Open access, a breakthrough for science 
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“...Our organizations believe that the NIH proposal balances the public interest in having 
enhanced access to federally- funded NIH research while allowing publishers sufficient 
market protections and time to implement new economic publishing models. In addition, this 
initiative is consonant with the market models that many publishers have adopted that place 
short- term embargoes on access to scientific literature. Timely access to the results of NIH- 
funded research is critical to maintaining the vitality of our Nation's investment in research 
and education. Such access is also critically important to taxpayers seeking needed 
information -- information that they have supported through their tax dollars -- concerning 
their health and welfare. We applaud your leadership and look forward to working with you 
as the initiative is implemented.” (Public letter to NIH Director Elias A. Zerhouni, Director by Prudence S. Adler, 
Association of Research Libraries, Miriam Nisbert, American Library Association; Mary Alice Baish, American Association 
of Law Libraries; Doug Newcomb, Special Libraries Assosiation)   
 Koudinov and Suber: Open access, a breakthrough for science 
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ORIGINAL STUDY CONCLUSION: OPEN ACCESS ARTICLES HAVE 
GREATER RESEARCH IMPACT  
Web-links rich gateway citation for this article is at http://neurobiologyoflipids.org/noteworthy/ 
 
Abstract: “Although many authors believe that their work has a greater research impact if it 
is freely available, studies to demonstrate that impact are few. This study looks at articles in 
four disciplines at varying stages of adoption of open access --philosophy, political science, 
electrical and electronic engineering and mathematics-- to see whether they have a greater 
impact as measured by citations in the ISI Web of Science database when their authors make 
them freely available on the Internet. The finding is that, across all four disciplines, freely 
available articles do have a greater research impact. Shedding light on this category of open 
access reveals that scholars in diverse disciplines are adopting open-access practices and 
being rewarded for it.” (Park et al. College and Research Libraries Sept 2004 65(5) Journal FileID=31968) 
 Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
25 
“SCIENTISTS, CONSIDER WHERE YOU PUBLISH” 
(By Michael Seringhaus, fourth-year graduate student in mol biophysics and biochemistry at Yale) 
Source: http://www.yaledailynews.com/article.asp?AID=26120 
 
      “For scientists, publishing a paper in a respected peer-reviewed journal marks the 
culmination of successful research. But some of the most prestigious and sought-after 
journals are so costly to access that a growing number of academic libraries can't afford to 
subscribe. Before submitting your next manuscript, consider a journal's access policy 
alongside its prestige -- and weigh the implications of publishing in such costly periodicals. 
   Two distinct problems continue to plague scientific publishing. First, institutional journal 
subscription costs are skyrocketing so fast that they outstrip the ability of many libraries to 
pay, threatening to sever scientists from the literature. Second, the taxpaying public funds a 
terrific amount of research in this country, and with few exceptions, can't access any of it. 
These problems share a common root - paid access to the scientific literature. Koudinov and Suber: Open access, a breakthrough for science 
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   Consider some figures. Subscription fee increases for academic journals have surpassed 
inflation six-fold throughout the past decade, and the sharpest increases belong to journal 
titles in medicine and the basic sciences. The Association of Research Libraries examined 
subscriber spending between 1986 and 2001: by 2001, libraries were spending three times as 
much for fewer serial titles. With fixed or declining budgets, some academic and institutional 
libraries can't afford to subscribe to all the journals their scientists demand. Many are cutting 
acquisitions in the humanities and social sciences to compensate, still unable to keep pace. 
Scientists are being saddled with a pretty lousy legacy. No wonder the French department 
hates us. 
   The dazzling rise in journal subscription costs is logical, considering publishers enjoy a 
monopoly over the articles in their journals. (If a researcher desperately needs an article 
published in Cell, a subscription to any other journal is useless.) Demand for titles is 
inherently inelastic, and publishers are free to command whatever prices they choose - 
schools pretty much have to ante up, until they simply can't afford to pay any more. Annual Koudinov and Suber: Open access, a breakthrough for science 
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fees climbing into seven figures saw one UCSF campus cut off from Elsevier's Cell Press 
journals last fall. Furious researchers demanded a boycott [AK: See Open letter on a call to 
boycott Cell Press, http://www.podbaydoor.com/mt/mt-comments.cgi?entry_id=1106 ], and 
Cell Press quickly renegotiated. But the problem remains -- when even massive state schools 
like UC cringe at subscription tolls, reform is past due. 
   This publication industry depends entirely upon scientists: our research articles, and our 
commitment to contribute time and expertise peer-reviewing the work of others are 
absolutely essential. Amazingly, we provide these crucial commodities to publishers free of 
charge. Elsevier has never uncovered a single scientific result, but they sure do make a 
killing selling our own data back to us. Some publishers aren't content to simply look; they've 
aimed a night-vision zoom-cam directly into the gift horse's mouth. 
   This fall is an exciting time: the government is finally taking action to ensure public access 
to taxpayer-funded research. By Dec. 1, the NIH - backed by the U.S. House of 
Representatives Appropriations Committee - will begin demanding that a full-text copy of Koudinov and Suber: Open access, a breakthrough for science 
Neurobiology of Lipids, 2004, Vol. 3, 6, http://neurobiologyoflipids.org/content/3/6 
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every NIH-funded manuscript be deposited in the established PubMed Central repository, 
available free of charge after a six-month holding period. And that's not all: any article whose 
publication costs were paid with NIH monies must be made available free of charge, 
immediately. 
   This open-archiving plan is a welcome development, addressing the urgent need for some 
form of taxpayer access to publicly funded basic research. But it does little to ease the burden 
borne by academic libraries. The requisite six-month embargo, among other considerations, 
ensures that institutions will still need paid journal subscriptions. 
   Some publishers are furious over the government directive, bemoaning this interference 
with free enterprise and their imminent loss of revenue. Elsevier has posted outlandish profits 
and enjoyed pristine stock ratings for years. Now, the spotlight is on them, the people 
demand open access, and the party's over. Blame my liberal leanings, but I'm unsympathetic 
to the cries of a cadre of profiteering monopolists. Koudinov and Suber: Open access, a breakthrough for science 
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   If you follow science opinion at all, you're probably familiar with the open-access debate, 
the upshot being something like this: big corporate publishers are evil but terrific for your 
career, and upstart open access journals are the squeaky-clean also-rans that won't help your 
chances of landing a job. The prestige of publishing in the old guard journals is undeniable, 
and by all accounts, intoxicating. 
      As students and young researchers, you may not yet enjoy ultimate control over the 
journals in which you publish. You may prefer to place your personal advancement over 
public access to your work -- and while the entrenched hierarchy continues to reward this 
behavior, you'll meet little opposition. But before you fire off that next manuscript to Cell, 
consider this: scientific journals exist to record and disseminate the research results, not to 
make publishers rich or restrict access to vital information. 
   Some journals are already working to provide some form of free access to published work -
- others steadfastly refuse and fight any government pressure to do so. True open access 
alternatives do exist, and with the arrival of high-profile journals like PLoS Biology they can Koudinov and Suber: Open access, a breakthrough for science 
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be quite prestigious indeed. Familiarize yourself with the landscape before choosing sides. 
As educated scientists, it may be refreshing to consider that where you publish is but a 
shorthand for the quality of your work. You do, always, have a choice.” (Michael Seringhaus, Yale 
Daily News, 8 September, 2004, http://www.yaledailynews.com/article.asp?AID=26120 ) 
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YOUNG SCIENTISTS, TAKE HOME THIS MESSAGE 
 
“As students and young researchers, you may not yet enjoy ultimate 
control over the journals in which you publish. You may prefer to 
place your personal advancement over public access to your work - 
and while the entrenched hierarchy continues to reward this 
behavior, you'll meet little opposition. But before you fire off that 
next manuscript to Cell, consider this: scientific journals exist to 
record and disseminate the research results, not to make publishers 
rich or restrict access to vital information.” 
(Source: Michael Seringhaus, Yale Daily News, 8 September, 2004, http://www.yaledailynews.com/article.asp?AID=26120 ) 